Company Summary:
Lila Sciences is a privately held, early-stage technology company pioneering the application of artificial intelligence to transform every aspect of the scientific method. Lila is backed by Flagship Pioneering, which brings the courage, long-term vision, and resources needed to realize unreasonable results. Join our mission-driven team and contribute to the future of science.
Our Life Sciences effort is leveraging AI and high-throughput automation for valuable therapeutic discovery and development across biological modalities.
At Lila, we are uniquely cross-functional and collaborative. We are actively reimagining the way teams work together and communicate. Therefore, we seek individuals with an inclusive mindset and a diversity of thought. Our teams thrive in unstructured and creative environments. All voices are heard because we know that experience comes in many forms, skills are transferable, and passion goes a long way.
If this sounds like an environment you’d love to work in, even if you only have some of the experience listed below, please apply.
Internship Opportunities:
Lila Science is considering talented individuals seeking hands-on experience as a Product Strategy MBA Summer Intern. In this role, will collaborate with our Product team, contributing to groundbreaking advancements, and playing a pivotal role in shaping the future of our platform.
All internship projects will involve working across one of the following domains. The following example projects are categorized by their primary domain. Please indicate in your cover letter your interest in one or more specific domains.
Market Intelligence & Competitive Analysis
Drive strategic insights through comprehensive research and analysis of emerging technology spaces. Projects may include:
- Developing and maintaining structured databases of industry players, from startups to research institutions
- Tracking industry developments and creating systematic approaches to market monitoring
- Building detailed profiles of key technical experts and thought leaders
Product and Technology Strategy
Support strategic product initiatives through market research and competitive analysis:
- Evaluate product opportunities and analyze competitive landscapes
- Develop business cases for emerging technology platforms
- Research business models, pricing strategies, and go-to-market approaches
- Identify and profile potential technical advisors and industry experts
Lab Operations Optimization
Help optimize laboratory and research operations through data-driven analysis:
- Analyze workflows and resource utilization
- Develop tools for capacity planning and resource allocation
- Identify operational bottlenecks and propose solutions
Customer Discovery
Lead structured research initiatives to understand customer needs:
- Develop frameworks for market segmentation and user personas
- Create and validate hypotheses about customer pain points
- Design comprehensive interview strategies and analysis frameworks
Internship Timeframes
We are considering candidates for various semester timeframes, including Summer and Fall 2025 internships. Please specify your availability in your application.
About Flagship
Flagship Pioneering is a platform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
At Flagship, we recognize there is no perfect candidate. If you have some of the experience listed above but not all, please apply anyway. Experience comes in many forms, skills are transferable, and passion goes a long way. We are dedicated to building diverse and inclusive teams and look forward to learning more about your unique background.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
What We Do
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability.
Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions.
The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).
